A carregar...
Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics
OBJECTIVE: To determine the association between genetic variants reported to impact risperidone and adverse events (AEs) in children and adolescents. METHODS: Individuals ≤18 years with ≥4 weeks of risperidone exposure in a de-identified DNA biobank were included. The primary outcome was AE frequenc...
Na minha lista:
| Publicado no: | J Dev Behav Pediatr |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995603/ https://ncbi.nlm.nih.gov/pubmed/33759847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/DBP.0000000000000883 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|